These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631 [TBL] [Abstract][Full Text] [Related]
8. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. KuoLee R; Harris G; Conlan JW; Chen W Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863 [TBL] [Abstract][Full Text] [Related]
9. Potential source of Francisella tularensis live vaccine strain attenuation determined by genome comparison. Rohmer L; Brittnacher M; Svensson K; Buckley D; Haugen E; Zhou Y; Chang J; Levy R; Hayden H; Forsman M; Olson M; Johansson A; Kaul R; Miller SI Infect Immun; 2006 Dec; 74(12):6895-906. PubMed ID: 17000723 [TBL] [Abstract][Full Text] [Related]
10. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751 [TBL] [Abstract][Full Text] [Related]
11. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism. Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834 [TBL] [Abstract][Full Text] [Related]
12. Deletion of the Bacillus anthracis capB homologue in Francisella tularensis subspecies tularensis generates an attenuated strain that protects mice against virulent tularaemia. Michell SL; Dean RE; Eyles JE; Hartley MG; Waters E; Prior JL; Titball RW; Oyston PCF J Med Microbiol; 2010 Nov; 59(Pt 11):1275-1284. PubMed ID: 20651039 [TBL] [Abstract][Full Text] [Related]
13. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Twine S; Byström M; Chen W; Forsman M; Golovliov I; Johansson A; Kelly J; Lindgren H; Svensson K; Zingmark C; Conlan W; Sjöstedt A Infect Immun; 2005 Dec; 73(12):8345-52. PubMed ID: 16299332 [TBL] [Abstract][Full Text] [Related]
14. Vaccines against Francisella tularensis. Wayne Conlan J; Oyston PC Ann N Y Acad Sci; 2007 Jun; 1105():325-50. PubMed ID: 17395730 [TBL] [Abstract][Full Text] [Related]
15. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine. Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model. Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073 [TBL] [Abstract][Full Text] [Related]
18. Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia. Jia Q; Bowen R; Dillon BJ; Masleša-Galić S; Chang BT; Kaidi AC; Horwitz MA Sci Rep; 2018 May; 8(1):7009. PubMed ID: 29725025 [TBL] [Abstract][Full Text] [Related]
19. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge. Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555 [TBL] [Abstract][Full Text] [Related]